3Molina R,Filella X,Auge JM.ProGRP:a new biomarker for small cell lung cancer[J].Clin Biochem,2004,37(7):505-511.
4Swellam M,Ragab HM,Abdalla NA,et al.Soluble cytokeratin-19 and E-selectin biomarkers:their relevance for lung cancer detection when tested independently or in combinations[J].Cancer Biomark,2008,4(1):43-54.
5Polberg K,Stepulak A,Zawislak J,et al.Squamous cell carcinoma antigen levels in patients with laryngeal cancer[J].Pol Merkur Lekarski,2005,19(111):375-376.
6Oremek GM,Sauer-Eppel H,Bruzdziak TH.Value of tumour and inflammatory markers in lung cancer[J].Anticancer Res,2007,27(4A):1911-1915.
7Tiseo M,Ardizzoni A,Cafferata MA,et al.Predictive and prognostic significance of neuron-specific enolase(NSE) in non-small cell cancer[J].Anticancer Res,2008,28(1B):507-513.
8Zweig HM,Campbell G. Receive-operating characteristic plots:a fundamental evaluation tool in clinical medicirne[J]. Clin Chcm, 1993,39(4) :561.
9Manuel Diez, Antonio Torres, Marina Pollan, et al. Prognostic Significance of serum CA125 antigen assay in patients with non-small cell lung cancer[J]. Caner, 1994 : 73 : 1368.
